These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 3882231)
1. Failure of 5-day vinblastine infusion in the treatment of patients with renal cell carcinoma. Tannock IF; Evans WK Cancer Treat Rep; 1985 Feb; 69(2):227-8. PubMed ID: 3882231 [No Abstract] [Full Text] [Related]
2. Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study. Samuels BL; Hollis DR; Rosner GL; Trump DL; Shapiro CL; Vogelzang NJ; Schilsky RL Clin Cancer Res; 1997 Nov; 3(11):1977-84. PubMed ID: 9815587 [TBL] [Abstract][Full Text] [Related]
3. Phase II study of continuous 5-day vinblastine infusion in renal adenocarcinoma. Kuebler JP; Hogan TF; Trump DL; Bryan GT Cancer Treat Rep; 1984 Jun; 68(6):925-6. PubMed ID: 6733709 [No Abstract] [Full Text] [Related]
4. [Progression of late metastases of renal cell carcinoma]. Wittekind C Dtsch Med Wochenschr; 2006 Apr; 131(17):994. PubMed ID: 16673224 [No Abstract] [Full Text] [Related]
5. [A case of lung metastasis from renal cell carcinoma showing complete response by a combination chemotherapy with methotrexate, vinblastine and pepleomycin (MVP)]. Tamaki M; Maeda S; Iwata H; Yamamoto N; Kuriyama M; Ban Y; Kawada Y Hinyokika Kiyo; 1995 Mar; 41(3):205-7. PubMed ID: 7741073 [TBL] [Abstract][Full Text] [Related]
6. An update on a case of regression of lung metastases after radiotherapy for bone metastasis in renal cell carcinoma. Jafri M; Protheroe A Clin Oncol (R Coll Radiol); 2008 May; 20(4):316. PubMed ID: 18329259 [No Abstract] [Full Text] [Related]
7. [Chemotherapy of renal cell carcinoma. 2. Combined chemotherapy using ACNU and VBL]. Kobayashi M; Imai K; Nakai K; Kumasaka F; Suzuki T; Ito Y; Yamanaka H; Sugihara S Hinyokika Kiyo; 1986 Mar; 32(3):375-83. PubMed ID: 3460318 [TBL] [Abstract][Full Text] [Related]
9. Lung and bone metastases from renal cell carcinoma responsive to bisphosphonates: a case report. Kijima T; Fujii Y; Suyama T; Okubo Y; Yonese J; Fukui I Int J Urol; 2008 Jun; 15(6):546-7. PubMed ID: 18489646 [TBL] [Abstract][Full Text] [Related]
10. [Circumvention of the multidrug-resistance in renal cancer by bisbenzylisoquinoline]. Kakehi Y; Hashimura T; Yoshida O; Segawa T; Kanematsu A Hinyokika Kiyo; 1993 Dec; 39(12):1227-32. PubMed ID: 8285174 [TBL] [Abstract][Full Text] [Related]
11. Treatment of renal cell carcinoma with alpha (human leukocyte) interferon and vinblastine in combination: a phase I-II trial. Figlin RA; deKernion JB; Maldazys J; Sarna G Cancer Treat Rep; 1985 Mar; 69(3):263-7. PubMed ID: 3978656 [TBL] [Abstract][Full Text] [Related]
12. [Intraarterial chemotherapy for metastatic renal cell carcinomas: combination with MDR-overcoming agents]. Kakehi Y; Yoshida O; Segawa T; Kanematsu A; Hiura M; Shichiri Y; Arai Y Hinyokika Kiyo; 1994 Oct; 40(10):925-9. PubMed ID: 7992710 [TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy of renal cell carcinoma. 3. Single-agent therapy with FT-207 or vinblastine]. Satomi Y; Senga Y; Fukuda M; Nakahashi M; Ohshima H; Furuhata A Nihon Hinyokika Gakkai Zasshi; 1984 Jun; 75(6):903-8. PubMed ID: 6438382 [No Abstract] [Full Text] [Related]
14. Interleukin-2, interferon-alpha, 5-fluorouracil, and vinblastine in the treatment of metastatic renal cell carcinoma: a prospective phase II study: the experience of Rambam and Lin Medical Centers 1996-2000. Gez E; Rubinov R; Gaitini D; Meretyk S; Best LA; Native O; Stein A; Erlich N; Beny A; Zidan J; Haim N; Kuten A Cancer; 2002 Oct; 95(8):1644-9. PubMed ID: 12365011 [TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy of metastatic renal cell carcinoma with cis-diamminedichloroplatinum and other drugs]. Okumura S; Nishimura T; Yoshida K; Ohhara M; Hasegawa J; Hirasawa S; Hara M; Kawamura N; Kanamori S; Akimoto M Hinyokika Kiyo; 1984 Sep; 30(9):1167-71. PubMed ID: 6084420 [TBL] [Abstract][Full Text] [Related]
16. Phase II study of 5-day infusion of vinblastine in patients with advanced ovarian carcinoma. Shah MK; St Marie K; Catalano RB; Dierks K; Creech RH Cancer Treat Rep; 1985 Feb; 69(2):229-30. PubMed ID: 3882232 [No Abstract] [Full Text] [Related]
17. [Evaluation of bone metastases from renal cell carcinoma]. Tsuda S; Koga S; Nishikido M; Tsurusaki T; Igawa T; Noguchi M; Kanda S; Matsuya F; Kanetake H Hinyokika Kiyo; 2001 Mar; 47(3):155-8. PubMed ID: 11329954 [TBL] [Abstract][Full Text] [Related]
18. Vinblastine and estramustine phosphate in metastatic renal cell carcinoma: a phase II trial of the Fox Chase Network. Haas NB; Giantonio BJ; Litwin S; Minniti CJ; Fox S; Yeslow G; Reilly R; Nahum K; Greenberg R; Halbherr T; Hudes GR Cancer; 2003 Nov; 98(9):1837-41. PubMed ID: 14584064 [TBL] [Abstract][Full Text] [Related]
19. Safety and activity of sorafenib in different histotypes of advanced renal cell carcinoma. Procopio G; Verzoni E; Gevorgyan A; Mancin M; Pusceddu S; Catena L; Platania M; Guadalupi V; Martinetti A; Bajetta E Oncology; 2007; 73(3-4):204-9. PubMed ID: 18418013 [TBL] [Abstract][Full Text] [Related]
20. [Evaluation of surgical treatment for bone metastatic lesion in renal cell carcinoma]. Mikami K; Nakagawa S; Sugimoto K; Nomoto T; Urano S; Nakamura T; Watanabe H Hinyokika Kiyo; 1995 Apr; 41(4):241-4. PubMed ID: 7785552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]